Carotid artery disease: selecting the appropriate asymptomatic patient for intervention

Area of Science:

• Vascular Surgery
• Neurology
• Preventive Cardiology

Background:

• Randomized controlled trials (RCTs) show carotid endarterectomy (CEA) benefits asymptomatic patients with severe carotid artery stenosis (CAS).
• Significant controversy persists regarding patient selection for CEA due to heterogeneous trial data.
• Variations in stenosis definitions, patient criteria, and outcome measures complicate interpretation of existing literature.

Purpose of the Study:

• To review RCTs on CEA versus medical management for asymptomatic severe CAS.
• To analyze stroke risk in asymptomatic patients with severe CAS.
• To identify high-risk patient subsets and evaluate medical therapy efficacy.

Main Methods:

• Systematic review of existing randomized controlled trials.
• Analysis of epidemiological data on stroke risk in severe CAS.
• Evaluation of medical therapy effectiveness in high-grade stenosis.

Main Results:

• CEA demonstrates superiority over medical management in preventing stroke for select asymptomatic patients.
• Identifying patients at highest risk for stroke is challenging due to data heterogeneity.
• Current medical therapies show variable efficacy in reducing stroke risk.

Conclusions:

• Optimizing patient selection for CEA is crucial to maximize prophylactic benefits.
• Minimizing complication rates during CEA is essential for maintaining treatment efficacy.
• Further research is needed to refine criteria for identifying high-risk asymptomatic patients eligible for intervention.